Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The wonder of RNA-based technology was long in its coming. But it has paid off throughout the COVID and post-COVID years. Plus, the breadth […]
RNA presents challenges, enormous opportunities, say biotech leaders Read More »
The law on every company’s and investor’s mind: the Inflation Reduction Act (IRA), which allows the government to set the prices of certain drugs.
How is the Inflation Reduction Act affecting biotech investment? Read More »
A lot of great science—and future cures—originates in a university. But while the majority of basic biological research is conducted in an academic setting,
How to succeed at tech transfer – and get great science to patients Read More »
The only constant is change. The trick for entrepreneurs and investors, it would seem, is to map and anticipate that change and operate with
What investors look for in early-stage companies Read More »
The Biotechnology Innovation Organization (BIO) Investor Forum 2023 is taking place October 17-18, 2023, in San Francisco, California, bringing together biotech startups and drug
BIO Investor Forum 2023 kicks off – here’s why biotech investment matters Read More »
Biotech was front and center as Biotechnology Innovation Organization (BIO) CEO Rachel King met with Maryland Governor Wes Moore at the University of Maryland
BIO CEO meets Maryland Governor to highlight state’s vital relationship with biotech Read More »
Within the challenging field of protein misfolding research, there is a company with a unique and competitive edge that is turning heads and making
BIO’s Emerging Start-Up Stadium winner: Paradox Immunotherapeutics Read More »
Out of the University of Miami, the industry’s first investigator-initiated emergency trial treating a pregnant mother has been authorized by the U.S. Food and
BIO’s Seed-Stage Start-Up Stadium winner: PriZm Therapeutics Read More »
The BIO Investor Forum 2023, hosted by the Biotechnology Innovation Organization (BIO), is right around the corner. Returning to San Francisco on October 17-18,
Why attend the BIO Investor Forum 2023? An investor and a company explain. Read More »
As part of our coverage of the National Institute of Health’s (NIH) Innovation Zone at the 2023 Biotechnology Innovation Organization (BIO) International Convention in Boston,
NIH Innovation Zone: OculoTherapy’s unique therapeutics for glaucoma and eye disease Read More »
